Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Australia's Immuron extends gains on positive results for diarrhea drug candidate

** Shares of Immuron  IMC.AX  rise as much as 36% to
A$0.170, their highest since Oct. 8, 2021
    ** IMC rose 89.4% in previous session; on track for its
biggest weekly gain since late July 2020
    ** Drug developer on Thursday reported positive results from
the clinical trials for its flagship diarhhea drug, Travelan
    ** About 12.2 mln shares change hands on Friday, compared
with the 30-day average volume of 1.3 mln
    ** Stock up 62.3% YTD, based on last close



 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))

Recent news on Immuron

See all news